Your browser doesn't support javascript.
loading
Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure.
Mezzano, D; Tagle, R; Pais, E; Panes, O; Pérez, M; Downey, P; Muñoz, B; Aranda, E; Barja, P; Thambo, S; González, F; Mezzano, S; Pereira, J.
Afiliación
  • Mezzano D; Department of Hematology-Oncology, School of Medicine, Catholic University of Chile, Santiago. dmezzano@med.puc.cl
Thromb Res ; 88(6): 465-72, 1997 Dec 15.
Article en En | MEDLINE | ID: mdl-9610957
ABSTRACT
Plasma von Willebrand factor antigen, soluble thrombomodulin, and tissue factor were increased in 31 patients with severe chronic renal failure (creatinine clearance <20 ml/min) under conservative treatment, whereas plasminogen activator inhibitor antigen did not differ significantly from healthy controls. No correlation among plasma levels of these proteins was found. Three patterns of relationship between endothelial cell markers and hemostatic defects were identified 1) Plasma thrombomodulin, a marker of endothelium damage, was found an independent predictor of bleeding time and platelet aggregation, and secretion defects, and was also related to the severity of renal failure; 2) von Willebrand factor antigen, an index of endothelial cell activation and secretion, was significantly correlated with intravascular markers of thrombin and plasmin generation and with platelet adenosine triphosphate content, but not with plasma creatinine levels; and 3) tissue factor and plasminogen activator inhibitor antigen levels were not statistically correlated with the diverse hemostatic defects. Activation of coagulation and fibrinolysis, secondary to endothelial cell activation, appearing early during the evolution of chronic renal failure, is pathogenically related to the platelet dysfunction, and probably to development of atherosclerosis and thrombotic events in this disease. The progression of chronic renal failure, through endothelial cell damage, would lead to aggravation of the platelet functional defect potentiating the hemorrhagic risk.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Uremia / Endotelio Vascular / Hemostasis / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Thromb Res Año: 1997 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Uremia / Endotelio Vascular / Hemostasis / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Thromb Res Año: 1997 Tipo del documento: Article
...